The page is the record's research on the issuer — no analyst, no rating, no view. # Armata Pharmaceuticals, Inc. (NYSE: ARMP) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Armata Pharmaceuticals, Inc., listed on the NYSE under ticker ARMP, with ISIN US04216R1023 and LEI 549300QM1VCWH8KT0S21. Its security type is Corporate and its segment is not on the record. Its sector is 2836 Biological Products, (No Diagnostic Substances) and its jurisdiction is United States, Washington. Its listing status is listed, not halted. ## The disclosure read The record holds 44 filings across 23 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 9.0 days, against a median of 6.0 days for NYSE issuers and 5.5 days for the sector. The latest filing is dated 2026-09-23 and is of type corporate_news, which is 46 days before the record date of 2026-11-08. The median latency is 4.0 days for both NYSE issuers and the sector. The record holds the median filings count at 64.0 for NYSE issuers and 65.5 for the sector, against 44 for the issuer. ## Auditor The auditor of record is Ernst & Young LLP, located in San Diego, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, since EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, since the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds the issuer's years 2021, 2022, 2023, 2024, 2025 and 2026 as sealed. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0000921114.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NYSE/ARMP (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/921114/000110465926034532/armp-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/ARMP (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/ARMP · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp